In the present study which the aim to evaluate the effect of hydrophilic polymer on the biopharmaceutical properties of metformin hydrochloride floating tablets, we have prepared floating systems using melt granulation, according to effervescent approach. Two hydrophilic polymers are used at various concentrations (10, 12.5, 15 and 17.5%), Acacia gum and hydroxypropylmethylcellulose (HPMC) at three viscosity grades (K4M, K15M and K100M). In addition to the satisfactory physical parameters, the evaluation of buoyancy and in vitro dissolution of floating developed systems revealed that the biopharmaceutical performances of these systems depended on the nature of the polymer. Unlike the acacia gum which did not produce floating systems, the HPMC matrixes had good buoyancy properties: fast buoyancy time (24030 to 360±30 sec) and total flotation time more than 24 hours with matrix maintained integrity. In addition, in the case of HPMC, a significant influence of viscosity grade on MTH kinetics has been demonstrated. Indeed, the observed results showed that at 17.5% of HPMC, as the viscosity grade increases, the dissolution kinetics of metformin HCl was extended. The formulations F8 (HPMC K15M) and F12 (HPMC K100M) have exhibited the drug release rates of about 92 and 80% respectively at the end of 8 hours dissolving. These formulations followed KorsmeyerPeppas/Higuchi release kinetics according to a Non-Fickian mechanism. Finally, the melting granulation process of MTH with stearic acid, in the case of HPMC K100M, used at high concentration (17.5%), has allowed the development of extended-release effervescent floating tablets ( 8 h).
Introduction
The oral route is the most convenient for administering the drugs. However, it has certain limitations for several active ingredients: unpredictable gastric emptying, rapid gastrointestinal transit and the existence of a narrow absorption window in the upper intestine. In order to overcome these physiological problems, the researchers chose to design delivery systems that would remain in the stomach for an extended period of time. This is the case with GRDDS: GastroRetentive Drug Delivery System, whose design can improve the oral bioavailability of drugs by extending the absorption phase [1-5. Several approaches to these systems are described in the literature [6-13.
For this study, metformin hydrochloride (MTH) was selected chosen as the molecule candidate. It is an oral antihyperglycemic agent of the biguanide class. Although its solubility in water is relatively high, the oral bioavailability of metformin hydrochloride is about 50-60%. This is mainly due to its low permeability (BCS III). Its narrow and limited absorption window at the upper part of the small intestine means that it is slowly and incompletely absorbed by the gastrointestinal tract [14-18.
The aim of this work devoted to development floating effervescent tablets of MTH, using a simple process, melt granulation, is to study the effect of hydrophilic polymers on the biopharmaceutical performances of the developed floating matrixes. For its realization, we have prepared floating systems using a simple manufacturing technique, solvents-free (aqueous or organic) and without drying step [19, melt granulation with a hydrophobic agent, stearic acid, according to an effervescent approach. The sodium bicarbonate was therefore introduced into the formulation of these systems as a carbon dioxide generating agent. A natural polysaccharide, Acacia gum and hydroxypropylmethylcellulose (HPMC) at three viscosity grades (K4M-K15M-K100M) were selected as hydrophilic polymers and were used at various concentrations (10, 12.5, 15 and 17.5%) for the preparation of floating systems.
Material and methods

Chemicals
Metformin hydrochloride (metformin HCl or MTH) (free sample) provided by Shangai Pharmaceutical, China, lot N° A-21411205109. Stearic acid supplied by Transmare Antwerpen N. V., Belgium. Hydroxypropylmethylcellulose: Methocel HPMC K4M supplied by Wolff Cellulosics Bayer, lot N° 30100513, Methocel HPMC K15M obtained from Colorcon, Royaume-Uni, lot N° ZK11012N03 and Benecel HPMC K100M received from ASHLAND, Germany, lot N°425718. Acacia gum received from Axo Pharma, Belgium, lot N°602.302. Sodium bicarbonate supplied by Sigma-Aldrich, Germany, lot N° 80370. Microcrystalline cellulose pH 102 (CMC) received from JRS Pharma, France, lot N° 5610262715. Talc and magnesium stearate supplied respectively by Guangxi Longguang Talc (lot N° 2015034 G), Development CO., Ltd., China and Anhui Sunhere Pharmaceutical Excipients CO, Ltd., China (lot N° 1514163).
Characterization of metformin HCl
The maximum of absorbance (λ max) is determined by scanning the spectrum of metformin hydrochloride solution 0.1N HCl (pH 1.2) at 200-400 nm using a UV-visible spectrophotometer (WPA Light II 7120 V 1.80). The metformin hydrochloride's calibration curve is performed by using twelve standards (5 to 60 mg/l) prepared by successive dilutions of a 1000 mg/l metformin HCl stock solution with 0.1N HCl (pH 1.2). The results are the average of three trials. The effervescent metformin hydrochloride floating tablets were prepared by melt granulation of stearic acid in the presence of hydrophilic polymers, Acacia gum and three viscosity grades of HPMC (K4M, K15M and K100M), used at various concentrations and an effervescent agent, sodium bicarbonate. The tablets were prepared according to the formulations shown in table 1. Stearic acid is melted at 58°C (near its melting point) in a mortar placed on an Ikamag RET heating plate. All the powders were accurately weighed (Sartorius ED153-CW balance) and passed through a sieve (800 µm). Except magnesium stearate and talc, all other ingredients were blended uniformly, before being mixed in the melted stearic acid in the mortar. The resulting mass is allowed to solidify at laboratory temperature. Then, this solidified mass was calibrated (1000 µm sieve) and lubricated (addition of talc and magnesium stearate) then compressed using a Frogerais Type A 307 alternative press equipped with a double set of flat punches and a 12 mm diameter die. The obtained tablets have the following characteristics: average weight, 500 mg, and diameter, 12 mm.
Preparation of metformin HCl floating tablets
Pre-compression evaluation
Prior to the compression, a rheological study is carried out on the granules according standard procedures [20. The granules were therefore evaluated for angle of repose, bulk and tapped densities, compressibility index (Carr's index) and Hausner's ratio.
Post-compression evaluation
The formulated tablets were evaluated for quality control tests like drug content, weight variation, hardness, friability and thickness [20, 21.
In vitro buoyancy study
The in vitro buoyancy is carried out according 
Evaluation of swelling index
This test evaluates water absorption characteristics. The pre-weighed individually tablets (W0) are placed separately in glass beaker containing 200 ml of 0.1 N HCl maintained at 37 ± 1 °C, without stirring, until 8 hours. At the end of each hour of the test, the swollen floating tablets are removed from beaker, and the excess water is gently removed with absorbent paper to remove the surface droplets and then re-weighed (Wt). The % swelling index (SI) is calculated by using the following equation:
Where, Wt = Weight of tablet at time t, W0 = Initial weight of tablet. The results expressed as % of gain in mass as a function of time are the average of three measures.
In vitro dissolution study
The in vitro dissolution study was performed using the USP II paddle apparatus, Erweka DT 80, at a rotational speed of 75 rpm. The floating tablets are introduced inside a beaker containing 900 ml of 0.1 N HCl dissolution medium, maintained at 37 ± 0.5°C. This study is done for 8 hours. Samples (5 ml) of the solution are withdrawn at time intervals of 20,40,60,90 and 120 minutes, then every hour up to 8 hours. Each volume withdrawn is replaced with the same volume of pre-warmed fresh dissolution media. The samples are filtered through 0.45 μm porosity syringe filter and diluted to a suitable concentration with 0.1 N HCl. Absorbance of these solutions was measured at 233 nm using UVvisible spectrophotometer (WPA Light II 7120 V 1.80). The percentage drug release was calculated by using calibration curve equation. The results of in vitro dissolution represent the average of six measures (MeanCV).
Modeling of dissolution kinetics
We have determined the release mechanism by fitting the dissolution data to the various kinetic equations: Zero order, Higuchi model; Qt = KH t ½
Korsmeyer and Peppas model:
( ∞ ) = log k + n log t
The diffusion exponent, "n" was calculated for characterizing the different release mechanisms. If n = 0.45 the diffusion is Fickian, if 0.45 < n < 0.89 the release mechanism is anomalous transport or non-Fickian, if n  0.89 the transport is of case II, if n > 0.89 the transport is of super case II.
The dissolution data was analyzed according to the different kinetic equations and the Correlation coefficient R 2 values were calculated of all batches and for each model.
Dissolution time of successive fractions
To best interpret release kinetics of metformin HCl from floating tablets, the times, T 25% , T 50% and T 80% were calculated from dissolution data according to the best fit model with the highest correlation coefficient R 2 using the following formulas [30:
Also, the mean dissolution time (MDT) was calculated from dissolution data using the following equation:
Where ti is the average time during which the fraction ∆Mi of the drug has been released from the pharmaceutical dosage form [31.
It should be noted that the times, T25%, T50% and T80% as well as the mean dissolution time (MDT) were used to evaluate the metformin HCl release and deduce the effectiveness of the matrix systems in slowing its dissolution. Indeed, the higher the dissolution time values of successive fractions, the more the floating system has the ability to retain the pharmaceutical ingredient. It should also be stressed that the value of MDT depends on the formulation factors (Nature, polymer concentration) and the physic-chemical properties of the molecule [30.
FTIR spectroscopy
Our study was completed by a FT-IR spectroscopy (Shimadzu IR Affinity 1S CE). This analysis was performed to investigate drug-excipient interactions. Samples of pure drug, stearic acid and floating matrices, F8 and F12, considered to promote MTH gastro-retention, were scanned in the spectral region of 4000 to 750 cm -1 with a resolution of 4 cm -1 .
Statistical analysis (ANOVA)
The results of in vitro release kinetics of metformin hydrochloride were statistically processed using GraphPadPrism 7 computer software to compare drug release profiles of MTH from floating systems prepared. Compare according to the nature, the concentration and the viscosity of the hydrophilic polymer. Statistical analyses were performed by onefactor analysis of variance (ANOVA). The differences were considered significant at p < 0.05 at a 95% confidence interval.
Results and discussion
Characterization of metformin hydrochloride
At   233 nm, analytical wavelength [32 the calibration curve is a straight line obeying Beer Lambert's law ( Figure 1 ). Linearity is between 5 and 60 mg/l metformin HCl dissolved in 0.1N HCl.
Figure 1
Calibration curve of metformin hydrochloride in 0.1 N HCl
Preliminary trials
According to the effervescent floating systems approach, preliminary trials were conducted to define the role of each ingredient of the formulation. Hydroxypropylmethylcellulose (HPMC) and acacia gum are used as hydrophilic polymer for extended metformin HCl release. Sodium bicarbonate is applied like an effervescent flotation agent, gas generating in contact the acid dissolving media. Stearic acid is used as a hydrophobic agent of melt granulation. Due to its low density and hydrophobic properties, stearic acid can improve floatation properties and slow the release of metformin HCl. Finally, talc and magnesium stearate are used as flow regulator and compression lubricant respectively. All formulas prepared F1 to F16 have shown in Table 1 . The granules of proposed formulations were evaluated for pre-compression parameters as shown in (Table 2) .
Pre-compression evaluation
Post-compression evaluation
The floating tablets obtained by melt-granulation were evaluated for post-compression parameters as indicate in table 3. All tablets have shown satisfactory and reproducible physical parameters (Table 3) : average level metformin HCl between 97.63 and 101.80%, weight uniformity within the prescribed limits; 500 ± 25 mg, sufficient hardness; in the range 4.99 ± 0.10 to 5.94 ± 0.54 kg/cm 2 . Thickness and percentage friability ranged from 3.43 ± 0.03 to 3.82 ± 0.05 mm and 0.52 to 0.90 % respectively. All formulations have shown less than 1% (w/w) friability. Finally, the physical characteristics of floating tablets of the formulations proposed have shown no significant variation. 
In vitro buoyancy study
It should be recalled that metformin HCl floating tablets were prepared by melt-granulation according effervescent approach using sodium bicarbonate as a gas generating agent. NaHCO3, in contact with dissolving medium 0.1 N HCl, generates CO2. The carbon dioxide thus generated is trapped in the tablet and protected inside the gel formed by the hydration of polymer. The tablet density decreases below 1 g/ml and, as a result, the matrix becomes floating [33.
The results of in vitro buoyancy study; floating lag time (FLT), matrix integrity and total floating time (TFT) for all formulations were given in Table 4 . These results have shown that buoyancy was dependent on formulation parameters. The buoyancy lags time of the formulations, F13, F14, F15 and F16 containing the acacia gum was more than 1 hour (no floating systems). With HPMC, the buoyancy lag time was short. It ranged from 240 ± 20 sec to 360 ± 30 sec. These might be due to rapid hydration of HPMC polymer, which results in a rapid flotation of the tablets compared to those tablets containing Acacia gum. All formulations with HPMC remained buoyant for more than 24 hours except for F1, F2, F3 and F4. The tablets of F1, F2 and F3, formulations with HPMC K4M have disintegrated rapidly after flotation. The tablets F4 have floated immediately but remained floating for less than 12 hours with a manifestation of surface erosion despite the maximum concentration of HPMC K4M (17.5%). These results could be attributed to the low viscosity grade of the HPMC K4M which has not allow the formation of a thick enough gelled layer resistant to the tensions generated by carbon dioxide release.
Except tablets obtained from F5, all the formulations with HPMC K15M and HPMC K100M corresponding respectively to F6-F7-F8 and F9-F10-F11-F12 were shown fast flotation time and total buoyancy time more than 24 hours with matrix integrity maintained. This could be explained by the high viscosity grade of HPMC K15M and K100M allowing sufficient hydration and gelling to retain the carbon dioxide bubbles generated by sodium bicarbonate in contact with dissolving media (H + ). F5 has shown short floating lag time (300 ± 30 sec), total floating time more than 24 hours but has manifested superficial erosion. This could be attributed to the low concentration of HPMC K15M (10%), which is insufficient to form a resistant gel barrier.
Finally, the results ( Table 4 ) clearly showed that buoyancy properties of metformin hydrochloride tablets depended on the formulation parameters, mainly on the nature of the polymer. In general, concentration does not affect the buoyancy properties of the prepared matrixes. Also, it was concluded that at high viscosity of HPMC, we observed the best flotation properties which are in the following order: HPMC K15MHPMC K4M and HPMC K100MHPMC K4M.
Evaluation of swelling index
The swelling is an important factor for buoyancy and dissolution kinetic of floating matrixes. The swelling index was observed every hour up to 8 hours for all formulations and the percentage swelling was determined at the end of each hour of the test. Figure 2 clearly has shown that as the concentration of HPMC (K15M or K100M) increases the swelling index also increases. This observation is particularly marked at concentrations 15 and 17.5% for the K100M ( Figure  2b ) and 17.5% for the K15M (Figure 2a ). 
In vitro dissolution studies
The dissolution data of metformin HCl floating tablets, F4 to F16, are shown in Table 5 . In Table 6 , we have mentioned the dissolution times T25%, T50%, T80% and the mean dissolution time (MDT) of formulations for which we have observed a prolonged release and the following buoyancy properties: short FLT, TFT > 24 hours and matrix integrity (F6 to F12). Figure 4 illustrates the influence of concentration of hydrophilic polymer. Figure 5 shows the dissolution profiles of metformin hydrochloride associated with the effect of hypromellose viscosity. 
Effect of hydrophilic polymer nature
The drug release kinetics was depended on the nature of the hydrophilic polymer. The results of in vitro dissolution studies mentioned in Table 5 clearly have indicated that, in the case of Acacia gum used as hydrophilic polymer, regardless of its concentration (10-12.5-15 and 17.5%), the in vitro release of metformin hydrochloride has not prolonged. Dissolution of drug was complete after 2 or 3 hours of testing (F13, F14, F15 and F16 ). This could be explained by the disintegration of the tablets after approximately 60-90 min of testing under the effect of stirring. Acacia gum therefore did not allow the formation of a thick enough gel layer able to retain the carbon dioxide generated by the effervescence of sodium bicarbonate in the 0.1 N HCl dissolution medium and to resist of the agitation speed. In contrast, with HPMC, we found that the drug release was significantly slowed and prolonged (6 H or  8 H) ( Table 5 ). The kinetics of drug release therefore depends on the nature of the hydrophilic polymer. A very significant difference (p0.05) was noted between the release kinetics (HPMC, GA) and the extended release is in the following order; HPMC K100MGA, HPMC K15MGA and HPMC K4MGA. Results in agreement with those of the flotation test.
Effect of HPMC concentration
The release profiles of floating tablets which related the effect of HPMC concentration were depicted in Figure 4 . This figure was showed that the dissolution kinetics was slowed and extended for HPMC at both viscosity grades (K15M and K100M). In both cases. it is slower at concentration, 17.5%. Figure 4 (a) indicated that in the case of the HPMC K15M, the kinetic was slowed down in the following order: F8F7F6F5. A not negligible difference between the dissolution profiles of formulations F8 and F5 was found from 3 hours onwards of kinetic; F8F5. Similarly, Figure 4 (b) shows that in the case of the HPMC K100M the kinetics was slowed down in the following order: F12F11F10F9. A significant difference between the release profiles of formulations F12 and F9 was found from 3 hours onwards of kinetics; F12F9 (p0.05). It was concluded that the formulations containing the HPMC with highest concentration (17.5%), F8 and F12 were exhibited extended release. Finally, the decrease in MTH release rate from the F8 (92.18%) ( Figure 4a ) and F12 (80%) (Figure 4b ) formulations could be explained as follows: at high concentration (17.5%) of HPMC (K15M or K100M), the viscosity of the gelled matrix increases following rapid hydration of the polymer, resulting in a decrease in the drug diffusion coefficient, thus controlling and slowing down the release of metformin hydrochloride into the dissolution medium. 
Effect of viscosity grade of HPMC
We have evaluated the influence of HPMC viscosity on the dissolution kinetics of metformin HCl from effervescent floating systems prepared. Three viscosity grades of HPMC were studied: HPMC K4M (low), HPMC K15M (medium) and HPMC K100M (high). The dissolution profiles depicted in Figure 5 have shown that for HPMC concentrations of 10, 12.5 and 15%, the viscosity grade has no effect on the release of metformin hydrochloride. The in vitro dissolution profiles are similar [ Figure 5 (a, b, c). No significant difference was found (p0.05). While at 17.5% polymer, viscosity has an influence on the kinetics: A significant difference was found between the in vitro release profiles of MTH; F8F4 and F12F4 (p0.05). The extended drug release is in order; F8F4 and F12F4 (Figure 5d ). A significant difference was noted between the kinetics of the formulations, F8 and F12 from the 3rd test hour (p0.05). The extended drug release is in this case; F12F8 (Figure 5d ). Generally speaking, at concentration 17.5% polymer, the drug release was slowed with the increase in viscosity grade in the following order: HPMC K100M>HPMC K15M>HPMC K4M. The floating tablets containing the highest viscosity polymer, HPMC K100M, at 17.5% (F12) exhibited significantly slowed dissolution kinetics with a rate about 80.00 at 8 hours.
Dissolution time of successive fractions
For each viscosity grade of HPMC, no significant difference (p0.05) was noted between the dissolution times of the successive fractions for concentrations 10, 12.5 and 15%. However, at 17.5% of HPMC, particularly HPMC K100M, the times, T25%, T50%, T80% were delayed and drug release was significantly extended. Indeed, the formulation, F12 (HPMC K100M 17.5%) has indicated respectively T25%, T50% and T80% of 1.1982-3.7160 and 8.0060 h compared to 0.7431-2.5670 and 5.9484 h, respectively, for the formulation, F8 (HPMC K15M 17.5%). In addition, the MDT values for these formulations are 3.0540 and 2.7863 h respectively (Table 6 ). It should also be noted that formulations F8 and F12 have indicated not complete dissolution with metformin hydrochloride release rates of 92.18 ± 1.09 and 80.00 ± 1.14% respectively at the end of 8 hours of testing (Table 5 ). Finally, it was concluded that at 17.5% of HPMC with highest viscosity (HPMC K100M), a slow and extended release of MTH was obtained from effervescent floating tablets prepared by melt granulation with stearic acid. Table 7 . By comparing the values of R 2 and n of different models, we can choose the model best suited to the release profile and deduce the release mechanism of metformin HCl from formulations prepared. In vitro release profiles from all formulations, F6 to F12 could be best expressed by the Higuchi and Krosmeyer-Peppas models as plots showed highest linearity with R 2 values of 0.995 to 0.998 and of 0.995 to 0.997 respectively. The release kinetics of F12 expressed by Krosmeyer-Peppas/Higuchi equations showed R 2 values equal to 0.997. In Krosmeyer-Peppas, the linear plot was for F8 with R 2 0.996 and in Higuchi R 2 0.997. Also, the diffusion exponent "n" values, for all formulations except F6 are above 0.45 (0.478-0.612). It was concluded that for formulations F7 to F12, the metformin HCl release from floating tablets follows a Non-Fickian mechanism (anomalous transport) (n between 0.45 and 0.89). Finally, this indicates that for these formulations, the drug release mechanism is controlled by more than one process: a mixed mechanism of diffusion and erosion. 
FTIR spectroscopy
The FTIR spectroscopy results are shown in Figures 6 and 7 . The IR spectra of the physical mixtures (M01-M02) ( Figure  6 ) and the floating formulations (F8-F12) (Figure 7 ) clearly show the characteristic absorption peaks of MTH as mentioned below:
-N-H; 3 High intensity absorption peaks around 3173, 3302 and 3375 cm -1 .
-C=N; two intense absorption bands at 1632 cm -1 and 1576 cm -1 .
-Aliphatic CH3; three absorption peaks around 1477, 1450 and 1410 cm -1 .
-C-N of aliphatic diamines; low intensity bands between 1250 and 1050 cm -1 .
These results confirm the identity of MTH in developed systems [34-36. Also, no interaction between the active ingredient and the excipient was detected by the FTIR spectroscopy. 
Conclusion
In this first experimental part, the results have shown the effect of nature of hydrophilic polymer on the biopharmaceutical behavior of metformin HCl floating tablets prepared by melt granulation. Unlike Acacia gum which alone has not produced conclusive results, HPMC has produced floating matrices with good buoyancy properties and extended release of metformin hydrochloride. Also, the drug release kinetic was found to be dependent on HPMC viscosity, particularly at the concentration 17.5%. At this concentration, when the viscosity grade of HPMC increases, the dissolution kinetic of metformin HCl was more slowed and extended. Indeed, the floating tablets F8 (HPMC K15M) and F12 (HPMC K100M) have exhibited extended release kinetics (>8 hours) with release rates of 92.181.09 and 80±1.14% respectively. These formulations can constitute promoter systems for the development of extended-release metformin HCl floating tablets. Also, it should be noted that infrared spectroscopy did not reveal any PA-Excipient interaction despite the melt granulation manufacturing process with stearic acid. Finally, in a next experimental step; we propose to improve the biopharmaceutical properties of the natural polysaccharide, Acacia gum.
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